智通财经APP讯，智云健康(09955)发布公告，于2025年3月10日，公司与该等认购人及独家配售代理订立认购协议，内容有关向该等认购人发行本金总额为450万美元的可换股债券。
可换股债券按初步转换价每股转换股份2.10港元(可予调整)获悉数兑换后，将发行合共1664.55万股转换股份，相当于公司现有已发行股本约2.58%及公司经发行转换股份扩大后已发行股本约2.51%。转换股份将根据一般授权配发及发行。
集团拟将按以下方式动用发行可换股债券的所得款项：约225万美元将用于发展集团的日常业务，包括患者到制造商(P2M)管道开发及药店SaaS(软件即服务)扩张等;及约225万美元将用作一般营运资金。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.